Mangaluru city police launches dedicated web portal, mobile app

Bengaluru, Mar 10: Congress leader NA Haris on Tuesday said that keeping Jammu and Kashmir leaders under house arrest is not democratic.

Speaking to media persons he said, "It is not done. Keeping the leaders under house arrest in Jammu and Kashmir is not democratic."

Haris said that nobody is talking about it. Prime Minister Narendra Modi is not talking about it and nothing is happing.

"About Kashmir, it is better to say less as nobody is talking about it. Prime Minister Narendra Modi is not talking about it and nothing is happening. It does not look good," he told media.

"I think leaders should be brought to the table and discussion on issues should take place. Do whatever has to be done for the country," he added.

The Jammu and Kashmir Administration had on February 5 invoked the Public Safety Act (PSA) against former Chief Ministers Mehbooba Mufti and Omar Abdullah. The duo was detained after the Central government abrogated Article 370 last year.

Bengaluru, Apr 17: The Ministry of Information and Broadcasting on Thursday served a show cause notice to a Kannada news channel for broadcasting a programme in which it purportedly said that the Centre would 'air drop money' to the poor, owing to the COVID-19 lockdown.

The notice said that the channel was "spreading false information, creating panic and social unrest.

" The channel had allegedly aired a show titled, "Helicopter Money" on Wednesday which claimed that the Centre would drop money from helicopters during the lockdown period.

A Twitter user took a serious note of it and complained to the Union Minister for Information and Broadcasting Prakash Javadekar.

The fact check team of the Press Information Bureau, under the Ministry of Information and Broadcasting, refuted the claim.

In its notice to the channel, PIB said, "You are hereby directed to show cause why your channel should not be taken out of air immediately. You are instructed to send your reply in this regard within 10 days of receipt of this notice."

Reacting to the notice, the management of the news channels said, "A programme which has been seen in bits and pieces and those who have not even seen the programme appears to have complained. Notice will be replied accordingly."

Mar 5: The government on Thursday asserted that there is no shortage of raw ingredients or medicines in the country as it has taken various initiatives to tackle the challenge posed by the coronavirus outbreak.

All initiatives are also being taken to ensure that there is no impact of the disease in India, Minister of Chemicals and Fertilizers D V Sadananda Gowda said.

"There is no shortage of any APIs in the country. We have sufficient APIs (active pharmaceutical ingredients) and medicines in the country," he said.

Gowda was addressing the 5th international exhibition and conference on the pharmaceutical and medical industry organised by the Department of Pharmaceuticals, Gujarat government and industry chamber Ficci here.

For another three months there is no shortage for undertaking production in the pharma sector, he added.

"Our government has taken all initiatives to ensure that as far as our country is concerned the coronavirus should be stopped, and there is no hazard as far as this issue is concerned," Gowda reiterated.

Coronavirus is a challenge and "we should make all efforts that need to be taken..., " he added.

On Tuesday, India, the world's largest maker of generic drugs, restricted the export of common medicines such as paracetamol and 25 other pharmaceutical ingredients and drugs made from them, as it looks to prevent shortages amid concerns of the coronavirus outbreak turning into a pandemic.

Besides over-the-counter painkiller and fever reducer paracetamol, drugs restricted for exports included common antibiotics metronidazole, and those used to treat bacterial and other infections as well as Vitamin B1 and B12 ingredients.

A notification by the Directorate General of Foreign Trade (DGFT) had said the export of 26 active pharmaceutical ingredients (APIs) and formulations would require licence.